Drug Trial Radar · NCT05172726
Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
58
Actual
Start
Dec 2, 2021
Primary completion
Oct 14, 2026
Study completion Oct 14, 2026
Sponsor
- Lead sponsor
- Organon and CoIndustry
- Sponsor type
- Industry
- First posted
- Dec 29, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, multi-center, Phase 3 study to evaluate tapinarof cream, 1% in pediatric subjects with plaque psoriasis.
Conditions
- Plaque Psoriasis
Interventions
tapinarof cream, 1%Drug
applied topically once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: Screening up to Week 53
- Number of subjects with clinically significant laboratory test abnormalitiesTime frame: Screening up to Week 53
- Number of subjects with clinically significant vital signs abnormalitiesTime frame: Screening up to Week 53
- Investigator-Assessed Local Tolerability Scale (LTS) ScoresTime frame: Baseline up to Week 52
- Subject (or Caregiver)-Assessed Local Tolerability Scale (LTS)Time frame: Baseline up to Week 52
Locations
19 sites in 2 countries. Site status is shown where the registry gives one.
Northwest Arkansas Clinical Trials Center, PLLC
Rogers, Arkansas
First OC Dermatology
Fountain Valley, California
Mission Dermatology Center
Rancho Santa Margarita, California
RM Medical Research
Miami Lakes, Florida
San Marcus Research Clinic, Inc.
Miami Lakes, Florida
Olympian Clinical Research
Tampa, Florida
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Dawes Fretzin Clinical Research Group
Indianapolis, Indiana
Options Research Group
West Lafayette, Indiana
Wright State Physicians Pharmacology Translational Unit
Fairborn, Ohio
Oregon Dermatology & Research Center
Portland, Oregon
Dermatology Specialists of Spokane
Spokane, Washington
Dermatology Research Institute Inc.
Calgary, Alberta, Canada
Rejuvenation Laser Dermatology Clinics
Edmonton, Alberta, Canada
Skincare Studio INC
St. John's, Newfoundland and Labrador, Canada
Lynderm Research Inc.
Markham, Ontario, Canada
Alliance Clinical Trials
Waterloo, Ontario, Canada
Whitby Health Centre Dermatology Trials
Whitby, Ontario, Canada
Innovaderm Research, Inc.
Montreal, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.